Search clinical trials for: GS-US-339-0103

Total 5561 results

Gilead Sciences

Completed

GS-5885, GS-9451, Tegobuvir and Ribavirin (RBV) in Interferon Ineligible or Intolerant Subjects With Chronic Genotype 1a or 1b Hepatitis C Virus (HCV) Infection

Chronic Genotype 1a or 1b HCV Infection

United States, Canada, Puerto Rico
Gilead Sciences

Completed

A Study Evaluating GS-9620 in Virologically Suppressed Subjects With Chronic Hepatitis B Virus Infection

Hepatitis B

Korea, Republic of, United States, Canada, Australia, New Zealand
Gilead Sciences

Completed

A Study Evaluating GS-9620 in Treatment Naive Subjects With Chronic Hepatitis B

Hepatitis B | HBV

Korea, Republic of, United States, Canada, Australia, New Zealand
Gilead Sciences

Completed

Surveillance Study of Respiratory Syncytial Virus Infection (RSV) in Subjects < 24 Months of Age

Respiratory Syncytial Virus Infections

United States
Gilead Sciences

Completed

A Study Evaluating GS-9620 in Treatment Naive Subjects With Chronic Hepatitis C

Hepatitis C

United States, Puerto Rico
Gilead Sciences

Completed

Study to Evaluate Switching From a Regimen Consisting of the Efavirenz/Emtricitabine/Tenofovir Disoproxil Fumarate Single-Tablet Regimen (STR) to the Emtricitabine/Rilpivirine/Tenofovir Disoproxil Fumarate STR

HIV-1 Infection

United States
Gilead Sciences

Completed

Safety, Tolerability, Pharmacokinetics and Antiviral Activity of GS-9669 in Subjects With Chronic Hepatitis C Virus Infection

Hepatitis C

United States, Puerto Rico
Gilead Sciences

Completed

Single Cohort 4-period Study to Assess Pharmacokinetics of Metformin Alone and in Combination With Ranolazine

Type 2 Diabetes Mellitus

United States
Gilead Sciences

Completed

Safety and Efficacy of Adefovir Dipivoxil in Children and Adolescents With Chronic Hepatitis B

Chronic Hepatitis B

United States
Gilead Sciences

Completed

A Study to Evaluate Tenofovir Disoproxil Fumarate (DF) in Asian-American Adults With Chronic Hepatitis B Infection

Chronic Hepatitis B

United States
Gilead Sciences

Completed

Treatment of Persistent Viremia (Virus in Blood) in Chronic Hepatitis B Subjects Already Receiving Adefovir Dipivoxil

Chronic Hepatitis B

France, Germany, United States, Spain
Philips Healthcare

Withdrawn

MRI/TRUS Fusion Guided Prostate Biopsy- An Improved Way to Detect and Quantify Prostate Cancer

Prostate Cancer

United States
Mirati Therapeutics Inc.

Terminated

Study of MGCD0103 (MG-0103) in Patients With Relapsed or Refractory Hodgkin's Lymphoma

Hodgkin's Lymphoma

United States, Canada
AmpliMed Corporation

Completed

Safety and Efficacy Trial of Imexon Plus DTIC in Advanced Malignant Melanoma

Malignant Melanoma

United States
Gilead Sciences

Terminated

Study to Evaluate the Efficacy and Safety of Tilpisertib in Adults With Moderately to Severely Active Ulcerative Colitis (Falcon)

Ulcerative Colitis

United States, France, Australia, Italy, Poland, Germany, Austria, Canada, Switzerland
Gilead Sciences
Ono Pharmaceutical Co. Ltd

Completed

Study to Evaluate Safety and Pharmacokinetics of GS-4059 (Tirabrutinib) in Healthy Volunteers and Participants With Rheumatoid Arthritis (RA)

Rheumatoid Arthritis

United States
Gilead Sciences

Terminated

Safety and Efficacy of Andecaliximab in Participants With Moderately to Severely Active Crohn's Disease

Crohn's Disease

Spain, United Kingdom, United States, France, Italy, Germany, New Zealand, Australia, Poland, South Africa, Hungary, Canada, Czechia
Gilead Sciences

Terminated

Effect of Eleclazine (GS-6615) on Exercise Capacity in Subjects With Symptomatic Hypertrophic Cardiomyopathy (LIBERTY-HCM)

Hypertrophic Cardiomyopathy

Australia, United States, Netherlands, Israel, Italy, France, Germany, United Kingdom
Mario Negri Institute for Pharmacological Research

Not yet recruiting

Blood Flow Conditions and Sounds in AVFs (APOLLO)

End Stage Renal Disease

Italy
Gilead Sciences

Withdrawn

GS-6615 in Adults With Chronic Stable Angina and Coronary Artery Disease

Ischemic Heart Disease
UPECLIN HC FM Botucatu Unesp

Unknown

Impact of Educational Group Intervention on the Consumption of Fruit and Vegetables (fvphc)

Adult | Inclusion Criteria: | No Pregnancy | No Lactation | No Morbidity

Brazil
rasha medhat abdul-hady

Unknown

Maternal Serum Alpha-fetoprotein Level May Predict the Presence of Morbid Adherent Placenta

Placenta Accreta

Egypt
Sunnybrook Health Sciences Centre
Exact Imaging

Recruiting

Optimization of Prostate Biopsy - Micro-Ultrasound Versus MRI (OPTIMUM)

Prostate Cancer

United States, Canada, Austria, France, Germany, Spain, Belgium
Mayo Clinic

Enrolling by invitation

Great Saphenous Vein Anatomy at the Proximal Medial Thigh as a Potential Site for Rescue Venous Access

Anatomy of the GSV for Rescue Peripheral IV Access

United States
Fondazione Toscana Gabriele Monasterio
Nicolaus Copernicus University

Recruiting

Ultrasound-guided Femoral Puncture to Reduce Access- Related Complications After TAVR: (ACCESS-TAVR SIRIO)

Transcatheter Aortic Valve Replacement

Italy
Gilead Sciences

Completed

Safety, Tolerability, and Efficacy of GS-4997 Alone or in Combination With Simtuzumab (SIM) in Adults With Nonalcoholic Steatohepatitis (NASH) and Fibrosis Stages F2-F3

Non-Alcoholic Steatohepatitis (NASH)

United States, Canada
Sumitomo Pharma America, Inc.

Terminated

A Phase 1b/2 Study of Alvocidib Plus Decitabine or Azacitidine in Patients With MDS

Myelodysplastic Syndromes (MDS)

United States
National Institute of Arthritis and Musculoskeletal...

Completed

Monoclonal Antibody Treatment for Systemic Lupus Erythematosus

Systemic Lupus Erythematosus

United States
Lawson Health Research Institute

Terminated

Percussion Device (PD) for Detection of Pneumothorax

Pneumothorax

Canada
National Taiwan University Hospital

Completed

Evaluation of Tumor Ablation Effects by Irreversible Electroporation for Patients With Malignant Liver Tumors

Malignant Liver Tumors

Taiwan
Hartford Hospital
Helse Stavanger HF

Unknown

Sildenafil in US Heart Failure Patients (SilHF-US) (SilHF-US)

Heart Failure | Pulmonary Hypertension

United States
University Hospital, Basel, Switzerland

Recruiting

Intraoperative Ultrasound Guided Compared to Stereotactic Navigated Ventriculoperitoneal Shunt Placement (NaVPS)

Hydrocephalus | Ventriculoperitoneal Shunt (VPS)

Switzerland
Philipp Fürnstahl
KU Leuven; Swiss Center for Musculoskeletal Imaging

Completed

Robot-Assisted US-Based Vertebral Segmentation for Pedicle Screw Trajectory Identification

Healthy

Switzerland
Gesynta Pharma AB
Ergomed

Completed

A Study to Investigate Safety of GS-248 and Efficacy on Raynauds' Phenomenon in Systemic Sclerosis

Systemic Sclerosis

United Kingdom, Poland, Belgium, Netherlands
Gilead Sciences

Completed

Pharmacokinetics of Eleclazine in Adults With Normal and Impaired Hepatic Function

Long QT Syndrome

United States, Romania, New Zealand, Germany
Shanghai Chest Hospital
Xiangya Hospital of Central South University; Air Force Military Medical University...

Unknown

ENB in the Diagnosis of Peripheral Pulmonary Nodules

Peripheral Pulmonary Nodules

China
Ola Kamal Mohammed Galal

Not yet recruiting

Percutaneous Versus EUS FNAC in Pancreatic Masses

Pancreatic Cyst | Pancreatic Neoplasm | Pancreatic Abscess
University of Tennessee
Le Bonheur Children's Hospital

Completed

Confirming Proper Replacement of Dislodged Gastrostomy Tubes in Pediatric Patients

Gastrostomy Complications | Gastrostomy Tube Site Complication

United States
S. Giacomo Hospital
University of Bari

Unknown

Lung Ultrasound in Diagnosis and Management of Bronchiolitis Bronchiolitis

Bronchiolitis

Italy
Gilead Sciences

Recruiting

Study of GS-0201 Alone and in Combination in Participants With Advanced Solid Tumors

Advanced Solid Tumors

United States, Israel
Gilead Sciences
National Institute on Drug Abuse (NIDA); National Institute of Allergy and... and other collaborators

Recruiting

Study of Lenacapavir and Emtricitabine/Tenofovir Disoproxil Fumarate (F/TDF) for Prevention of HIV in People Who Inject Drugs (HPTN 103) (PURPOSE 4)

Pre-Exposure Prophylaxis of HIV Infection

United States
Gilead Sciences
HIV Prevention Trials Network

Recruiting

Study of Lenacapavir and Emtricitabine/Tenofovir Disoproxil Fumarate (F/TDF) in Prevention of HIV in Cisgender Women in the United States (HPTN 102) (PURPOSE 3)

Pre-Exposure Prophylaxis of HIV Infection

United States
Gilead Sciences

Recruiting

Study of GS-0272 in Participants With Rheumatoid Arthritis (MARASLE)

Rheumatoid Arthritis

United States, United Kingdom, Georgia, Moldova, Republic of
Gilead Sciences

Active, not recruiting

A Study of GS-5423 and GS-2872 in Combination With Capsid Inhibitor Lenacapavir in Virologically Suppressed Adults With HIV-1 Infection

HIV Infections

United States, Australia, Puerto Rico, Canada
Gilead Sciences

Terminated

Drug-Drug Interaction Study of Vesatolimod in Adults With HIV-1 Who Have Very Low or Undetectable Virus Levels

Human Immunodeficiency Virus Type 1 (HIV-1) Infection

United States
Gilead Sciences

Completed

Study to Evaluate the Safety and Efficacy of Lenacapavir in Combination With Other Antiretroviral Agents in People Living With HIV (CALIBRATE)

HIV-1-infection

United States, Puerto Rico, Dominican Republic
Sierra Oncology LLC - a GSK company

Completed

Momelotinib in Transfusion-Dependent Adults With Primary Myelofibrosis (PMF) or Post-polycythemia Vera or Post-essential Thrombocythemia Myelofibrosis (Post-PV/ET MF)

Primary Myelofibrosis (PMF) | Post-polycythemia Vera (Post-PV) Myelofibrosis | Postessential Thrombocythemia (Post-ET) Myelofibrosis

United States, Canada
Gilead Sciences

Completed

Study to Evaluate the Safety, Tolerability, and Antiviral Activity of Selgantolimod (Formerly GS-9688) in Viremic Adult Participants With Chronic Hepatitis B (CHB) Who Are Not Currently on Treatment

Chronic Hepatitis B

Korea, Republic of, Canada, Taiwan
Gilead Sciences

Completed

Evaluate the Safety and Effectiveness of Sovaldi in Participants With Chronic Hepatitis C Virus (HCV) Infection in Korea

Hepatitis C Virus

Korea, Republic of
Gilead Sciences

Terminated

Study of Single Agent Idelalisib Followed by Idelalisib in Combination With Chemotherapy in Adults With Metastatic Pancreatic Ductal Adenocarcinoma

Previously Untreated Pancreatic Ductal Adenocarcinoma | Relapsed/Refractory Pancreatic Ductal Adenocarcinoma

United States

3

Subscribe